Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Annals of Nuclear Medicine|April 10, 2004
Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PETHiroshi Ninomiya, Noboru Oriuchi, Nasim Kahn, et al.
EJNMMI Research|June 2, 2017
Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PETKeishi Horiguchi, Masahiko Tosaka, Tetsuya Higuchi, et al.
Annals of Nuclear Medicine|August 16, 2005
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imagingMei Tian, Hong Zhang, Tetsuya Higuchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 5, 2013
Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibodyHirofumi Hanaoka, Masahide Kuroki, Aiko Yamaguchi, et al.
Annals of Nuclear Medicine|February 6, 2008
Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinomaBishnuhari Paudyal, Noboru Oriuchi, Pramila Paudyal, et al.
Scientific Reports|May 22, 2019
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paragangliomaHiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, et al.
Annals of Nuclear Medicine|September 17, 2015
Evaluation of bone scan index change over time on automated calculation in bone scintigraphyRini Shintawati, Arifudin Achmad, Tetsuya Higuchi, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma: a study protocolAnri Inaki, Kenichi Yoshimura, Toshinori Murayama, et al.
Oral Radiology|February 20, 2019
18F-FDG and 18F-FAMT PET-derived metabolic parameters predict outcome of oral squamous cell carcinomaMai Kim, Tetsuya Higuchi, Takahito Nakajima, et al.
Molecular Imaging and Biology|December 4, 2019
Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([18F]FAMT) Uptake in Patients with Lung CancerKimihiro Shimizu, Kyoichi Kaira, Tetsuya Higuchi, et al.
Pageof 15